再生醫學市場：按組織類型、應用、最終用戶和地區分類

Regenerative Therapies Market, By Tissue Type, By Application type, By End user, By Geography

出版日期: 2026年03月31日 | 出版商:

Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到2026年，再生醫學市場規模將達到1,451.6億美元，到2033年將達到4,078億美元。預計從2026年到2033年，該市場將以15.9%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	1451.6億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	15.90%	2033年市場規模預測：	4078億美元

利用幹細胞進行治療的再生醫學是醫學領域發展最快的領域之一。隨著老齡化或受傷，人體難以獲得維持正常功能所需的最佳幹細胞數量。再生醫學的目標是增強人體自身的修復能力，滿足病人的需求。整形外科是再生醫學的一個分支，它透過刺激肌肉骨骼細胞再生來發揮人體自身的癒合能力。 Histogen公司是整形外科再生醫學產品的生產商之一，其產品－人類細胞外基質（hECM）－具有抗發炎和促血管生成作用，能夠刺激損傷部位幹細胞的增殖，從而誘導組織再生。

市場動態

再生醫學市場正迅速擴張，其主要驅動力是人們對能夠修復和再生受損組織和器官的創新治療方法的需求日益成長。幹細胞療法、組織工程和基因療法的進步塑造了市場動態，並推動了市場成長。儘管面臨成本和監管複雜性等挑戰，但持續的技術進步和不斷增加的研發投入仍在推動市場發展。隨著人們意識的提高和臨床證據的積累，再生醫學市場有望透過提供突破性解決方案和改善患者預後，徹底改變醫療保健產業。

阻礙全球再生醫學市場發展的因素。

組織工程和生物醫學工程領域缺乏標準化指南預計將阻礙全球再生醫學市場的成長。此外，臨床試驗週期過長會延緩產品上市，預計也將是限制市場成長的因素之一。

本次調查的主要特點

本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、區域前景以及主要參與者採取的競爭策略。
本研究根據以下參數分析了全球再生醫學市場的主要參與者：公司概況、財務績效、產品系列、企業發展區域、分銷策略、主要發展、策略和未來計劃。
透過利用本報告中的見解，企業負責人和經營團隊將能夠就未來的產品發布、技術升級、市場擴張和行銷策略做出明智的決策。
這份全球再生醫學市場報告的目標受群眾外包括產業內的各種相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
透過市場分析中使用的各種策略矩陣，相關人員可以更輕鬆地做出決策。

公司簡介
- Shire Pharmaceuticals
- Kinetic Concepts, Inc.
- Mesoblast Ltd.
- Metcela Inc.
- Nuo Therapeutics（Cytomedix Inc.）
- Integra LifeSciences
- Advanced Cell Technology, Inc.
- BioStem Life Sciences
- Akron Biotechnology, LLC
- Organovo Holdings Inc.
- Orgenesis Inc.
- Pluristem Therapeutics Inc.
- Genzyme
- Athersys, Inc.
- RenovaCare, Inc.
- Cytori Therapeutics, Inc.

第9章

參考
調查方法

簡介目錄

Product Code: CMI3712

Regenerative Therapies Market is estimated to be valued at USD 145.16 Bn in 2026 and is expected to reach USD 407.80 Bn by 2033, growing at a compound annual growth rate (CAGR) of 15.9% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 145.16 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	15.90%	2033 Value Projection:	USD 407.80 Bn

Regenerative medicine is one the fastest emerging fields of medicine, as it adopts stem cells for treatment. Increasing age or injury, makes it difficult to provide the optimum amount of stem cells that are needed to maintain the normal function. The goal of regenerative medicine is to amplify this natural repair system to keep pace with the demands of the patients. Orthopedics is one of the fields of regenerative medicine, which adopts natural healing process by stimulating regeneration of cells in the musculoskeletal system. Histogen Inc. is one of the manufacturer of orthopedic regenerative medicine and its product Human Extracellular matrix (hECM) is anti-inflammatory, angiogenic, and can stimulate growth of stem cells in damaged areas to induce tissue regeneration.

Market Dynamics

The regenerative therapy market is witnessing rapid expansion due to the increasing demand for innovative treatments that can restore and regenerate damaged tissues and organs. Market dynamics are being shaped by advancements in stem cell therapies, tissue engineering, and gene therapy, which are driving the market's growth. Despite challenges related to cost and regulatory complexities, continuous technological advancements and growing investments in research and development are driving the market forward. As awareness grows and clinical evidence accumulates, the regenerative therapy market is poised to transform healthcare by offering transformative solutions and improving patient outcomes.

Restraints of the Global Regenerative Therapies Market

Lack of standardized guidelines on tissue and bio-medical engineering is expected to hinder growth of the global regenerative therapies market. Moreover, lengthy clinical trials leading to delayed entry of products in the market is expected to restrain growth of the market.

Key features of the study

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global regenerative therapies market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Shire Pharmaceuticals, Kinetic Concepts, Inc., Mesoblast Ltd., Metcela Inc., Nuo Therapeutics (Cytomedix Inc.), Integra LifeSciences, Advanced Cell Technology Inc., BioStem Life Sciences,Akron Biotechnology, LLC, Organovo Holdings Inc., Orgenesis Inc., Pluristem Therapeutics Inc., Genzyme, Athersys, Inc., RenovaCare, Inc., Cytori Therapeutics, Inc.
Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The global regenerative therapies market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Market Segmentation

Global Regenerative Therapies Market, By Tissue Type (Revenue, USD Bn, 2021 - 2033)
Allograft
Xenograft
Alloplast
Global Regenerative Therapies Market, By Application (Revenue, USD Bn, 2021 - 2033)
Soft Tissue Repair
Cardiovascular
Dental
Orthopedic
CNS disease treatment
Others
Global Regenerative Therapies Market, By End User (Revenue, USD Bn, 2021 - 2033)
Hospitals
Ambulatory Surgical Centers
Educational Institutes
Global Regenerative Therapies Market, By Geography (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Europe
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Middle East
- GCC
- Israel
- Rest of Middle East
Africa
- Central Africa
- South Africa
- North Africa
Company Profiles
Shire Pharmaceuticals
Kinetic Concepts, Inc.
Mesoblast Ltd.
Metcela Inc.
Nuo Therapeutics (Cytomedix Inc.)
Integra LifeSciences
Advanced Cell Technology, Inc.
BioStem Life Sciences
Akron Biotechnology, LLC
Organovo Holdings Inc.
Orgenesis Inc.
Pluristem Therapeutics Inc.
Genzyme
Athersys, Inc.
RenovaCare, Inc.
Cytori Therapeutics, Inc.

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Tissue Type
- Market Snippet, By Application
- Market Snippet, By End User
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Key Developments
Regulatory Scenario
PEST Analysis

4. Global Regenerative Therapies Market, By Tissue Type, 2021 - 2033(US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033(%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Allograft
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
Xenograft
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
Alloplast
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends

5. Global Regenerative Therapies Market, By Application, 2021 - 2033(US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033(%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Soft Tissue Repair
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Cardiovascular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Dental
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Orthopedic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
CNS disease treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)

6. Global Regenerative Therapies Market, By End User, 2021 - 2033(US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033(%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Educational Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)

7. Global Regenerative Therapies Market, By Regions, 2021 - 2033(US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033(%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Company Profiles
- Shire Pharmaceuticals
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Kinetic Concepts, Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Mesoblast Ltd.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Metcela Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Nuo Therapeutics (Cytomedix Inc.)
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Integra LifeSciences
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Advanced Cell Technology, Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- BioStem Life Sciences
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Akron Biotechnology, LLC
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Organovo Holdings Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Orgenesis Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Pluristem Therapeutics Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Genzyme
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Athersys, Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- RenovaCare, Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Cytori Therapeutics, Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies